This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shenzhen Yhlo Biotech Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Liqiang Wu
Introduction
Liqiang Wu is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of virus detection, particularly in the development of antibodies for medical applications. His work is crucial in the ongoing fight against viral infections, including COVID-19.
Latest Patents
Liqiang Wu holds a patent for IgA antibodies and kits capable of specifically recognizing the RBD protein. This patent relates to the technical field of virus detection and provides a method for detecting IgA antibodies against the RBD protein of SARS-CoV-2. The antibody serves as a calibrator, enabling automated, high-throughput, and rapid detection of IgA antibodies against novel coronavirus pneumonia.
Career Highlights
Liqiang Wu is associated with Shenzhen Yhlo Biotech Co., Ltd., where he applies his expertise in biotechnology and medical diagnostics. His innovative work has positioned him as a key figure in the development of diagnostic tools that enhance the detection of viral infections.
Collaborations
Liqiang Wu collaborates with notable colleagues, including Fangming Cheng and Xiaotao Lin. Their combined efforts contribute to advancements in the field of biotechnology and medical research.
Conclusion
Liqiang Wu's contributions to the field of virus detection through his innovative patents and collaborations highlight his importance as an inventor. His work continues to impact the medical community positively, particularly in the context of viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile